A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application - PubMed (original) (raw)
Review
. 2013 Dec;14(12):1212-8.
doi: 10.1038/ni.2762.
Affiliations
- PMID: 24240160
- DOI: 10.1038/ni.2762
Free article
Review
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
Taku Okazaki et al. Nat Immunol. 2013 Dec.
Free article
Abstract
PD-1, a negative coreceptor expressed on antigen-stimulated T cells and B cells, seems to serve as a 'rheostat' of the immune response. The molecular mechanisms of the functions of PD-1, in conjunction with the mild, chronic and strain-specific autoimmune phenotypes of PD-1-deficient mice, in contrast to the devastating fatal autoimmune disease of mice deficient in the immunomodulatory receptor CTLA-4, suggest that immunoregulation by PD-1 is rather antigen specific and is mainly cell intrinsic. Such unique properties make PD-1 a powerful target for immunological therapy, with highly effective clinical applications for cancer treatment.
Similar articles
- T cell checkpoint regulators in the heart.
Grabie N, Lichtman AH, Padera R. Grabie N, et al. Cardiovasc Res. 2019 Apr 15;115(5):869-877. doi: 10.1093/cvr/cvz025. Cardiovasc Res. 2019. PMID: 30721928 Free PMC article. Review. - PD-1 signaling pathway in sepsis: Does it have a future?
Chen R, Zhou L. Chen R, et al. Clin Immunol. 2021 Aug;229:108742. doi: 10.1016/j.clim.2021.108742. Epub 2021 Apr 24. Clin Immunol. 2021. PMID: 33905818 Review. - Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
Fife BT, Bluestone JA. Fife BT, et al. Immunol Rev. 2008 Aug;224:166-82. doi: 10.1111/j.1600-065X.2008.00662.x. Immunol Rev. 2008. PMID: 18759926 Review. - Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Zhang B, Chikuma S, Hori S, Fagarasan S, Honjo T. Zhang B, et al. Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8490-5. doi: 10.1073/pnas.1608873113. Epub 2016 Jul 7. Proc Natl Acad Sci U S A. 2016. PMID: 27410049 Free PMC article. - Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.
Arruda LCM, de Azevedo JTC, de Oliveira GLV, Scortegagna GT, Rodrigues ES, Palma PVB, Brum DG, Guerreiro CT, Marques VD, Barreira AA, Covas DT, Simões BP, Voltarelli JC, Oliveira MC, Malmegrim KCR. Arruda LCM, et al. Clin Immunol. 2016 Aug;169:47-57. doi: 10.1016/j.clim.2016.06.005. Epub 2016 Jun 16. Clin Immunol. 2016. PMID: 27318116
Cited by
- Antagonistic roles of cGAS/STING signaling in colorectal cancer chemotherapy.
Liang B, Xing X, Storts H, Ye Z, Claybon H, Austin R, Ding R, Liu B, Wen H, Miles WO, Fishel R, Wang JJ. Liang B, et al. Front Oncol. 2024 Oct 14;14:1441935. doi: 10.3389/fonc.2024.1441935. eCollection 2024. Front Oncol. 2024. PMID: 39469633 Free PMC article. - Cadonilimab (PD-1/CTLA-4) in combination with lenvatinib in unresectable hepatocellular carcinoma (uHCC): A retrospective real-world study.
Yuan G, Chen Y, Zhu P, Deng Q, Su K, Liu J, Wang Y, Li R, Li W, Zang M, Hu X, Wang JJ, Li Q, Du Y, Chen J. Yuan G, et al. Heliyon. 2024 Sep 16;10(19):e37616. doi: 10.1016/j.heliyon.2024.e37616. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39398001 Free PMC article. - PET radiomics in lung cancer: advances and translational challenges.
Zhang Y, Huang W, Jiao H, Kang L. Zhang Y, et al. EJNMMI Phys. 2024 Oct 3;11(1):81. doi: 10.1186/s40658-024-00685-5. EJNMMI Phys. 2024. PMID: 39361110 Free PMC article. Review. - Vitreous metastasis from cutaneous melanoma: diagnosis and management.
Ashkenazy N, Harbour JW, Dubovy SR, Albini TA, Sridhar J, Patel N, Hansen ED, Uchiyama E, Rubsamen PE, Correa ZM. Ashkenazy N, et al. Arq Bras Oftalmol. 2023 Apr 17;87(5):e20220215. doi: 10.5935/0004-2749.2022-0215. eCollection 2023. Arq Bras Oftalmol. 2023. PMID: 39298731 Free PMC article. - Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications.
Zheng X, Sun R, Wei T. Zheng X, et al. Front Immunol. 2024 Sep 3;15:1438235. doi: 10.3389/fimmu.2024.1438235. eCollection 2024. Front Immunol. 2024. PMID: 39290709 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1997 May 27;94(11):5744-9 - PubMed
- Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13866-71 - PubMed
- Immunity. 1997 May;6(5):583-9 - PubMed
- Crit Rev Oncog. 1996;7(5-6):433-56 - PubMed
- Nature. 2006 Feb 9;439(7077):682-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical